Stay updated on Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial page.

Latest updates to the Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial page
- Check5 days agoChange DetectedThe web page has updated its version to v2.16.5, while the previous version v2.16.4 has been removed. Additionally, a note regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.SummaryDifference0.8%
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.7%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check41 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check70 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check84 days agoChange DetectedThe page has undergone significant updates, including the addition of new collaborators and investigators related to a study on bladder cancer, as well as a revision update from v2.14.4 to v2.15.0. Notably, detailed information about the study's patient enrollment criteria and treatment protocols has been removed.SummaryDifference43%
Stay in the know with updates to Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial page.